阿拉伯国家可持续医疗保健系统的公平金融框架。

IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Wadi B Alonazi, Sahar Alkhawtani
{"title":"阿拉伯国家可持续医疗保健系统的公平金融框架。","authors":"Wadi B Alonazi, Sahar Alkhawtani","doi":"10.17219/acem/195571","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Disparities persist in access, quality and outcomes across different socioeconomic strata. Addressing these disparities requires a comprehensive understanding of the underlying factors contributing to healthcare inequities. Even though healthcare equity has been discussed in the literature, no comprehensive frameworks have been developed considering the given country's distinctive demographic cultural and socioeconomic variables.</p><p><strong>Objectives: </strong>This study proposed an equity-based financial framework to enhance the sustainability of the healthcare system in Saudi Arabia, the United Arab Emirates (UAE) and Qatar. Moreover, this research aimed to examine the key factors influencing equitable access to healthcare services.</p><p><strong>Material and methods: </strong>A cross-sectional study design was employed, utilizing national health accounts, demographic surveys and health outcomes data from 3 Arab countries: Saudi Arabia, UAE and Qatar. The study included participants from 15 medical organizations, 500 policymakers and 10,000 patients. A stratified random sampling technique was employed to ensure a diverse and representative sample. The economic equity measurements included the principal component analysis (PCA) and Theil index. Financial sustainability was evaluated using techniques such as the cost-effectiveness analysis (CEA) and systems dynamics modeling techniques.</p><p><strong>Results: </strong>This study identified a positive convergence in healthcare systems among Qatar, Saudi Arabia and the UAE. The Theil index value of 0.35 suggested a balanced distribution of healthcare resources across the 3 countries. Policy A had an incremental cost-effectiveness ratio (ICER) of $15,000 per quality-adjusted life year (QALY), making it more cost-effective compared to Policy B with an ICER of $20,000 per QALY and Policy C with an ICER of $25,000 per QALY. The Delphi technique achieved a consensus level of 90%, while Policy C emerged as the most preferred option in the multi-criteria decision analysis (MCDA), scoring a total of 85 points. Moreover, the PCA accounted for 60% of the variations related to healthcare equity in the specified countries.</p><p><strong>Conclusions: </strong>The findings of this study provide valuable insights for policymakers, offering a new roadmap for economic evaluation studies aimed at enhancing healthcare equity and sustainability in Arab countries.</p>","PeriodicalId":7306,"journal":{"name":"Advances in Clinical and Experimental Medicine","volume":"34 4","pages":"507-527"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An equity-based financial framework for a sustainable healthcare system in Arab countries.\",\"authors\":\"Wadi B Alonazi, Sahar Alkhawtani\",\"doi\":\"10.17219/acem/195571\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Disparities persist in access, quality and outcomes across different socioeconomic strata. Addressing these disparities requires a comprehensive understanding of the underlying factors contributing to healthcare inequities. Even though healthcare equity has been discussed in the literature, no comprehensive frameworks have been developed considering the given country's distinctive demographic cultural and socioeconomic variables.</p><p><strong>Objectives: </strong>This study proposed an equity-based financial framework to enhance the sustainability of the healthcare system in Saudi Arabia, the United Arab Emirates (UAE) and Qatar. Moreover, this research aimed to examine the key factors influencing equitable access to healthcare services.</p><p><strong>Material and methods: </strong>A cross-sectional study design was employed, utilizing national health accounts, demographic surveys and health outcomes data from 3 Arab countries: Saudi Arabia, UAE and Qatar. The study included participants from 15 medical organizations, 500 policymakers and 10,000 patients. A stratified random sampling technique was employed to ensure a diverse and representative sample. The economic equity measurements included the principal component analysis (PCA) and Theil index. Financial sustainability was evaluated using techniques such as the cost-effectiveness analysis (CEA) and systems dynamics modeling techniques.</p><p><strong>Results: </strong>This study identified a positive convergence in healthcare systems among Qatar, Saudi Arabia and the UAE. The Theil index value of 0.35 suggested a balanced distribution of healthcare resources across the 3 countries. Policy A had an incremental cost-effectiveness ratio (ICER) of $15,000 per quality-adjusted life year (QALY), making it more cost-effective compared to Policy B with an ICER of $20,000 per QALY and Policy C with an ICER of $25,000 per QALY. The Delphi technique achieved a consensus level of 90%, while Policy C emerged as the most preferred option in the multi-criteria decision analysis (MCDA), scoring a total of 85 points. Moreover, the PCA accounted for 60% of the variations related to healthcare equity in the specified countries.</p><p><strong>Conclusions: </strong>The findings of this study provide valuable insights for policymakers, offering a new roadmap for economic evaluation studies aimed at enhancing healthcare equity and sustainability in Arab countries.</p>\",\"PeriodicalId\":7306,\"journal\":{\"name\":\"Advances in Clinical and Experimental Medicine\",\"volume\":\"34 4\",\"pages\":\"507-527\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Clinical and Experimental Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17219/acem/195571\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17219/acem/195571","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:不同社会经济阶层在获取、质量和结果方面存在差异。解决这些差异需要全面了解导致医疗保健不平等的潜在因素。尽管在文献中讨论了医疗公平,但考虑到给定国家独特的人口、文化和社会经济变量,没有制定全面的框架。目的:本研究提出了一个以股权为基础的金融框架,以增强沙特阿拉伯、阿拉伯联合酋长国(阿联酋)和卡塔尔医疗保健系统的可持续性。此外,本研究旨在探讨影响公平获得医疗保健服务的关键因素。材料和方法:采用横断面研究设计,利用来自沙特阿拉伯、阿联酋和卡塔尔3个阿拉伯国家的国民健康账户、人口调查和健康结果数据。这项研究包括来自15个医疗机构、500名政策制定者和1万名患者的参与者。采用分层随机抽样技术,确保样本的多样性和代表性。经济公平度量包括主成分分析(PCA)和Theil指数。财务可持续性评估使用技术,如成本效益分析(CEA)和系统动力学建模技术。结果:本研究确定了卡塔尔、沙特阿拉伯和阿联酋之间医疗保健系统的积极趋同。Theil指数为0.35,表明三国卫生资源分布较为均衡。保单A的增量成本效益比(ICER)为每个质量调整生命年(QALY) 15,000美元,与保单B(每个质量调整生命年的ICER为20,000美元)和保单C(每个质量调整生命年的ICER为25,000美元)相比,更具成本效益。德尔菲技术达到了90%的共识水平,而政策C在多标准决策分析(MCDA)中成为最受欢迎的选择,得分为85分。此外,PCA占指定国家中与医疗公平相关的60%的差异。结论:本研究的发现为决策者提供了有价值的见解,为旨在提高阿拉伯国家医疗公平和可持续性的经济评估研究提供了新的路线图。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An equity-based financial framework for a sustainable healthcare system in Arab countries.

Background: Disparities persist in access, quality and outcomes across different socioeconomic strata. Addressing these disparities requires a comprehensive understanding of the underlying factors contributing to healthcare inequities. Even though healthcare equity has been discussed in the literature, no comprehensive frameworks have been developed considering the given country's distinctive demographic cultural and socioeconomic variables.

Objectives: This study proposed an equity-based financial framework to enhance the sustainability of the healthcare system in Saudi Arabia, the United Arab Emirates (UAE) and Qatar. Moreover, this research aimed to examine the key factors influencing equitable access to healthcare services.

Material and methods: A cross-sectional study design was employed, utilizing national health accounts, demographic surveys and health outcomes data from 3 Arab countries: Saudi Arabia, UAE and Qatar. The study included participants from 15 medical organizations, 500 policymakers and 10,000 patients. A stratified random sampling technique was employed to ensure a diverse and representative sample. The economic equity measurements included the principal component analysis (PCA) and Theil index. Financial sustainability was evaluated using techniques such as the cost-effectiveness analysis (CEA) and systems dynamics modeling techniques.

Results: This study identified a positive convergence in healthcare systems among Qatar, Saudi Arabia and the UAE. The Theil index value of 0.35 suggested a balanced distribution of healthcare resources across the 3 countries. Policy A had an incremental cost-effectiveness ratio (ICER) of $15,000 per quality-adjusted life year (QALY), making it more cost-effective compared to Policy B with an ICER of $20,000 per QALY and Policy C with an ICER of $25,000 per QALY. The Delphi technique achieved a consensus level of 90%, while Policy C emerged as the most preferred option in the multi-criteria decision analysis (MCDA), scoring a total of 85 points. Moreover, the PCA accounted for 60% of the variations related to healthcare equity in the specified countries.

Conclusions: The findings of this study provide valuable insights for policymakers, offering a new roadmap for economic evaluation studies aimed at enhancing healthcare equity and sustainability in Arab countries.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in Clinical and Experimental Medicine
Advances in Clinical and Experimental Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
3.70
自引率
4.80%
发文量
153
审稿时长
6-12 weeks
期刊介绍: Advances in Clinical and Experimental Medicine has been published by the Wroclaw Medical University since 1992. Establishing the medical journal was the idea of Prof. Bogumił Halawa, Chair of the Department of Cardiology, and was fully supported by the Rector of Wroclaw Medical University, Prof. Zbigniew Knapik. Prof. Halawa was also the first editor-in-chief, between 1992-1997. The journal, then entitled "Postępy Medycyny Klinicznej i Doświadczalnej", appeared quarterly. Prof. Leszek Paradowski was editor-in-chief from 1997-1999. In 1998 he initiated alterations in the profile and cover design of the journal which were accepted by the Editorial Board. The title was changed to Advances in Clinical and Experimental Medicine. Articles in English were welcomed. A number of outstanding representatives of medical science from Poland and abroad were invited to participate in the newly established International Editorial Staff. Prof. Antonina Harłozińska-Szmyrka was editor-in-chief in years 2000-2005, in years 2006-2007 once again prof. Leszek Paradowski and prof. Maria Podolak-Dawidziak was editor-in-chief in years 2008-2016. Since 2017 the editor-in chief is prof. Maciej Bagłaj. Since July 2005, original papers have been published only in English. Case reports are no longer accepted. The manuscripts are reviewed by two independent reviewers and a statistical reviewer, and English texts are proofread by a native speaker. The journal has been indexed in several databases: Scopus, Ulrich’sTM International Periodicals Directory, Index Copernicus and since 2007 in Thomson Reuters databases: Science Citation Index Expanded i Journal Citation Reports/Science Edition. In 2010 the journal obtained Impact Factor which is now 1.179 pts. Articles published in the journal are worth 15 points among Polish journals according to the Polish Committee for Scientific Research and 169.43 points according to the Index Copernicus. Since November 7, 2012, Advances in Clinical and Experimental Medicine has been indexed and included in National Library of Medicine’s MEDLINE database. English abstracts printed in the journal are included and searchable using PubMed http://www.ncbi.nlm.nih.gov/pubmed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信